Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Surgical & Medical Instruments & Apparatus

Stryker Corp to acquire Inari Medical, Inc.

Announced Jan 6, 2025 · Closed Feb 19, 2025

Deal value$4.90BEV $4.86B
Premium61.0%To unaffected price
EV / Adj. EBITDA—8.5x EV / Revenue
ConsiderationAll cash$80.00 per share

Transaction

Acquirer
Stryker Corp (SYK)
Target
Inari Medical, Inc. (NARI)
Buyer type
Strategic
Offer price per share
$80.00
Enterprise value
$4.86B
Status
Closed Feb 19, 2025

Deal protections

Break fee (target pays)
$163M · 3.3%
Reverse fee (buyer pays)
—
Go-shop
No-shop
Financing
—

Advisors

To the acquirer
Not disclosed
To the target
Morgan Stanley

Sector context · Healthcare

Comparable deals
95 in the prior 24 months
Premium
61.0% vs. 67.0% sector median
EV / Adj. EBITDA
Sector median 14.5x
Break fee
3.3% vs. 3.5% sector median

Timeline

  1. AnnouncedJan 6, 2025
  2. Tender offerJan 17, 2025
  3. ClosedFeb 19, 2025
Sources
  • 8-K (EX-99) · Jan 6, 2025
  • 8-K · Jan 6, 2025
  • SC TO-C (EX-99.1) · Jan 7, 2025

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.